Stock Analysts

Intercept Pharmaceuticals’ OCA Now Breakthrough Therapy

Intercept Pharmaceuticals, Inc. ( ICPT ) announced that its lead candidate, obeticholic acid (OCA) has been granted Breakthrough Therapy designation by the FDA for the treatment of non-alcoholic steatohepatitis (NASH) in patients suffering from liver fibrosis. The company stated that according to recent epidemiological studies, over 10% of the U.S. […]

Stock Analysts

KB Home (KBH) Opens Ponderosa Ridge Community, Denver

KB Home ( KBH ) recently unveiled a community in Aurora, CO called Ponderosa Ridge. Built in the Denver-area neighborhood, the Ponderosa Ridge community will offer easy access to retail destinations, employment centers and other recreational attractions. People opting for homes at the Ponderosa Ridge community can choose from two floor plans, namely The Reserve and The Estates […]

Downgrades

Anadarko Petroleum Corporation (APC) Downgraded by Zacks to UNDERPERFORM

Zacks Investment Research downgraded shares of Anadarko Petroleum Corporation (APC) from NEUTRAL to UNDERPERFORM on January 30, 2015, with a target price of $73.00. Anadarko Petroleum derives more than half of its revenues from sales of oil and condensate. Global supply of crude oil is mounting while demand for the same is not increasing at the same pace, resulting in supply glut and leading to a free fall in oil prices […]

Stock Analysts

Will Low Realizations Hit ExxonMobil (XOM) Q4 Earnings?

ExxonMobil Corporation ( XOM ), the U.S. energy behemoth, is set to release fourth-quarter 2014 financial results before the opening bell on Monday, Feb 2, 2015. The company reported strong results in the trailing four quarters, beating the Zacks Consensus in all four with a positive average surprise of 6.89%. […]